Revisiting UGT1A1 Pharmacogenetic Testing Before Irinotecan—Why Not?

American Society of Clinical Oncology, JCO Oncology Practice, 4(18), p. 281-282, 2022

Journal article published in 2022 by Lukas P. Emery

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by